Form 8-K · Current Report · Filed 2026-09-08
Boston Scientific Discloses Material Cybersecurity Incident Impacting Operations
Boston Scientific Corporation disclosed a material cybersecurity incident on August 25, 2026, which affected its information technology systems and led to a global disruption in operations.
- Filer
- Boston Scientific Corporation BSX · NYSE
- Filed
- Accession
- 0000885725-26-000059
- CIK
- 0000885725
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The incident involved unauthorized activity on certain systems, causing a network outage that impacted manufacturing and order processing. The company has activated its incident response protocols and is working with third-party experts to investigate and restore operations. As of September 7, 2026, the company has not identified evidence of ongoing unauthorized access. The incident is expected to have a material impact on the company's results of operations for the third quarter and full year 2026, and the company believes it is unlikely to meet previously provided guidance. The company intends to provide an update on its operational and financial outlook during its planned conference call on October 28, 2026.
Items reported
Reported Item
Market reaction
Close before filing
$47.80
Since filing
+0.0%
Latest close
$47.80
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from BSX reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, BSX insiders reported 10 Form 4 transactions — net buying of $14.2M.
About Boston Scientific Corporation
Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.
Never miss another BSX filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.